News & Events
August 17, 2021
Celebrating National Nonprofit Day and Sharing C-Path UpdatesAs we observe National Nonprofit Day and recognize the invaluable effort nonprofits put towards making an impact in our communities and across the globe, this seemed like a perfect opportunity to reshare some of the year’s accomplishments, championed by the talented and unshakeable team at C-Path, our consortia members and collaborators. Read our August 2021......
May 18, 2021
C-Path Request for Proposal for External CommunicationsCritical Path Institute (C-Path) is seeking a proposal, including timelines and budget, for external marketing, communications, public relations and related services. C-Path Request for Proposal for External Communications...
April 6, 2021
C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate DirectorC-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science Consortium. D-RSC is currently engaged in several modeling projects of biomarkers and outcome measures, all at different stages in development and regulatory review, as well as development of a platform trial protocol for Duchenne and considering a new patient reported outcome instrument.......
March 31, 2021
Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific DirectorC-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelerator-Data and Analytics Platform initiative. Dr. Bétourné will work with the RDCA-DAP team to expand its reach into new diseases areas accessing new data and enhancing C-Path’s relationships within the rare disease community. Dr. Bétourné holds......
July 30, 2020
C-Path Partners with CHDR to Expand Global CollaborationsThe Critical Path Institute and the Centre for Human Drug Research (CHDR) have joined forces to expand global collaborations for both organizations. The initiative brings together stakeholders from each side with the objective of increasing actionable solutions for drug development and public health. The partnership allows CHDR to become involved in other areas of interest......